Stockscreener 앱 받기
3.575
1.38%
-0.045
전일 마감가:
$3.62
열려 있는:
$3.58
하루 거래량:
8,783
Relative Volume:
0.02
시가총액:
$1.11B
수익:
$563.46M
순이익/손실:
$27.92M
주가수익비율:
37.09
EPS:
0.0964
순현금흐름:
$-146.33M
1주 성능:
-5.80%
1개월 성능:
+2.88%
6개월 성능:
-55.21%
1년 성능:
-59.39%
1일 변동 폭
$3.55
$3.58
1주일 범위
$3.335
$3.79
52주 변동 폭
$3.03
$11.85
Alvotech Stock (ALVO) Company Profile
Compare ALVO vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
3.55 | 1.13B | 563.46M | 27.92M | -146.33M | 0.0964 |
TAK
Takeda Pharmaceutical Co Adr
|
17.76 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
117.78 | 49.56B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.8251 | 43.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.84 | 35.89B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
575.17 | 25.06B | 3.18B | 1.33B | 1.04B | 27.90 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-11-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-02-14 | 개시 | UBS | Buy |
| 2024-01-29 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-09-21 | 개시 | Barclays | Equal Weight |
| 2022-09-07 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-09-06 | 다운그레이드 | Citigroup | Buy → Sell |
| 2022-07-26 | 개시 | Citigroup | Buy |
모두보기
Alvotech 주식(ALVO)의 최신 뉴스
ALVO SEC FilingsAlvotech 10-K, 10-Q, 8-K Forms - Stock Titan
ALVO Technical Analysis & Stock Price Forecast - Intellectia AI
Alvotech: Improving Fundamentals Signal Potential Bottom For This Biosimilar Player (ALVO) - Seeking Alpha
Retail Trends: Whats the outlook for Alvotech Equity Warrants sector2026 Snapshot & Safe Entry Trade Reports - baoquankhu1.vn
Alvotech’s Price Rises But Technical Signals Turn Bearish - Bitget
Performance Recap: Is Alvotech a top pick in the sector2026 Trade Ideas & Long-Term Growth Plans - baoquankhu1.vn
Why Is Alvotech (ALVOW) Stock Down Today? - Meyka
Alvotech stock: Biosimilar innovator with global growth potential - AD HOC NEWS
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Alvotech (NASDAQ:ALVO) Stock Price Down 9.5%Here's What Happened - MarketBeat
Alvotech Plummets 9.5% Amid Market Volatility and Sector Uncertainty - Bitget
Alvotech CCO Anil Okay steps down to become Adalvo CEO - MSN
Published on: 2026-04-07 05:57:03 - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Trading Up 7.2%Here's What Happened - MarketBeat
ETFs Investing in Alvotech Stocks - TradingView
Institution Moves: Is Alvotech stock overvalued or fairly pricedMarket Movers & Weekly High Return Forecasts - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Stock Rating Lowered by Wall Street Zen - MarketBeat
ALVO Should I Buy - Intellectia AI
ALVO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag - MSN
Alvotech (ALVO) revenue surges 21% year-over-year in 2025 - MSN
ALVO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Alvotech Earnings Call: Growth Momentum Meets FDA Risk - The Globe and Mail
Alvotech (ALVO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alvotech (ALVO) Revenue Surges 21% Year-Over-Year in 2025 - Insider Monkey
Does Alvotech’s (ALVO) Reaffirmed 2026 Revenue Target Redefine Its Biosimilar Strategy Narrative? - Sahm
Alvotech’s comprehensive biosimilars platform presents an uneven risk-reward profile as the market factors in the FDA approval challenge - Bitget
Alvotech : Transactions of Managers and Closely Associated Persons - marketscreener.com
Alvotech : Managers’ transactionsManager Transaction NotificationATP ehf.EN - marketscreener.com
Alvotech : Managers' transactionsALVOTECH - MarketScreener
Alvotech Files Annual Report 2025 with the U.S. SEC - Quiver Quantitative
Alvotech Files Annual Report with the SEC - The Manila Times
Alvotech files Annual Report with the SEC - GlobeNewswire
Alvotech Publishes 2025 Annual Report - GlobeNewswire
Alvotech (NASDAQ: ALVO) turns 2025 profit while managing heavy debt and FDA CRLs - Stock Titan
Alvotech (NASDAQ:ALVO) Shares Up 5.3%Time to Buy? - MarketBeat
Short Interest in Alvotech (NASDAQ:ALVO) Drops By 17.0% - MarketBeat
Alvotech Stock: Biosimilar Innovator Positions for U.S. Market Expansion Amid Global Growth Push - AD HOC NEWS
Alvotech (NASDAQ:ALVO) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Alvotech Faces Weak Start with 6.54% Gap Down Amid Market Concerns - Markets Mojo
Retail Trends: What is the dividend yield of Alvotech Equity WarrantMarket Rally & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Alvotech (NASDAQ:ALVO) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Fed Meeting: Whats the fair value of Alvotech stock2026 Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn
Statutory Earnings May Not Be The Best Way To Understand Alvotech's (NASDAQ:ALVO) True Position - Yahoo Finance
Alvotech Shares Plunge to New 52-Week Low at $3.03 - Markets Mojo
Alvotech stock hits new 52-week low on UBS price target cut to $6 amid biosimilar launch delays - AD HOC NEWS
Alvotech (NASDAQ:ALVO) Sets New 12-Month Low After Analyst Downgrade - MarketBeat
Alvotech price target lowered to $4 from $5 at Barclays - TipRanks
Alvotech Drops 14% Amid Prevailing Negative Market Sentiment - Bitget
Alvotech price target lowered to $4 from $8 at Deutsche Bank - TipRanks
Barclays Lowers Price Target for Alvotech (ALVO) to $4.00, Maint - GuruFocus
Alvotech (ALVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.28%
자본화:
|
볼륨(24시간):